no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A Case Report of Myoclonus-Dystonia with Isolated Myoclonus Phenotype and Novel Mutation Successfully Treated with Deep Brain Stimulation
|
Besa Lehmann, Valentina |
|
|
9 |
1 |
p. 187-191 |
article |
2 |
A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis
|
Allan, Michelle |
|
|
9 |
1 |
p. 85-92 |
article |
3 |
Care Among Migraine Patients in a Commercially Insured Population
|
Bonafede, Machaon |
|
|
9 |
1 |
p. 93-103 |
article |
4 |
Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know
|
AlJumah, Mohamed |
|
|
9 |
1 |
p. 11-23 |
article |
5 |
Correction to: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMSII Trials
|
Ghezzi, Angelo |
|
|
9 |
1 |
p. 193-195 |
article |
6 |
Cost-Effectiveness of IncobotulinumtoxinA in the Treatment of Sialorrhea in Patients with Various Neurological Conditions
|
Makino, Koji |
|
|
9 |
1 |
p. 117-133 |
article |
7 |
Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical Benefit
|
Merola, Aristide |
|
|
9 |
1 |
p. 25-41 |
article |
8 |
Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years
|
Merlini, Giampaolo |
|
|
9 |
1 |
p. 105-115 |
article |
9 |
Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review
|
AlSharoqi, Isa Ahmed |
|
|
9 |
1 |
p. 55-66 |
article |
10 |
Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy
|
González‐Duarte, Alejandra |
|
|
9 |
1 |
p. 135-149 |
article |
11 |
Knowledge Is Power, but Is Ignorance Bliss? Optimising Conversations About Disease Progression in Multiple Sclerosis
|
Vermersch, Patrick |
|
|
9 |
1 |
p. 1-10 |
article |
12 |
Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife
|
Kritikos, Minos |
|
|
9 |
1 |
p. 159-171 |
article |
13 |
Potentially Inappropriate Medications in a Psychogeriatric Inpatient Ward: An Audit Based on Beers Criteria
|
Moebs, Isabelle |
|
|
9 |
1 |
p. 151-157 |
article |
14 |
Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing–Remitting Multiple Sclerosis: Quantifying the Patient’s Perspective
|
Meca-Lallana, José |
|
|
9 |
1 |
p. 173-179 |
article |
15 |
Real-World Treatment of Patients with Multiple Sclerosis per MS Subtype and Associated Healthcare Resource Use: An Analysis Based on 13,333 Patients in Germany
|
Müller, Sabrina |
|
|
9 |
1 |
p. 67-83 |
article |
16 |
Tardive Reactivation of Progressive Multiple Sclerosis During Treatment with Biotin
|
Demas, Alexis |
|
|
9 |
1 |
p. 181-185 |
article |
17 |
The Misdiagnosis of CIDP: A Review
|
Allen, Jeffrey A. |
|
|
9 |
1 |
p. 43-54 |
article |